layoffs

Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Flag link:
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Flag link:
Walgreens cutting 10% of corporate workforce, including in Deerfield and Chicago
Walgreens cutting 10% of corporate workforce, including in Deerfield and Chicago
Chicago Sun Times
Walgreens
layoffs
opioids
legal
Flag link:
More Layoffs Signal COVID-19 Testing Boom Is Over
More Layoffs Signal COVID-19 Testing Boom Is Over
Medical Devices and Diagnostics Industry
Abbott Labs
layoffs
Medtech
diagnostics
COVID-19
Flag link:
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BioSpace
BenevolentAI
layoffs
Flag link:
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Fierce Biotech
Affimed
layoffs
lymphoma
Flag link:
Cook Set to Layoff 500 Employees
Cook Set to Layoff 500 Employees
Medical Devices and Diagnostics Industry
Cook Medical
layoffs
Medtech
devices
device manufacturing
Flag link:
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Motley Fool
Novavax
Pharma CEOs
John C. Jacobs
vaccines
layoffs
COVID-19/flu vaccines
Flag link:
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Medical Marketing and Media
layoffs
Bristol Myers Squibb
Roche
Takeda
Gossamer Bio
Novavax
Flag link:
Gossamer cuts loose 25% of its staff, ties future to phase 3 trial of tarnished Merck rival
Gossamer cuts loose 25% of its staff, ties future to phase 3 trial of tarnished Merck rival
Fierce Biotech
Gossamer Bio
layoffs
seralutinib
Merck
PAH
Flag link:
Novavax cuts headcount by 25%, hitting hundreds of jobs, to align costs with dwindling COVID-19 market
Novavax cuts headcount by 25%, hitting hundreds of jobs, to align costs with dwindling COVID-19 market
Fierce Biotech
Novavax
layoffs
vaccines
COVID-19
Flag link:
Takeda Cuts 180+ Jobs Amid Pipeline Shake-Up
Takeda Cuts 180+ Jobs Amid Pipeline Shake-Up
BioSpace
Takeda
layoffs
Massachusetts
Flag link:
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model
BioSpace
Bristol Myers Squibb
layoffs
R&D
New Jersey
Flag link:
Layoffs Strike Thermo Fisher as COVID-19 Testing Demand Wanes
Layoffs Strike Thermo Fisher as COVID-19 Testing Demand Wanes
Medical Devices and Diagnostics Industry
Thermo Fisher Scientific
diagnostics
layoffs
COVID-19
Flag link:
Sangamo to lay off 120 as it pares pipeline
Sangamo to lay off 120 as it pares pipeline
BioPharma Dive
Sangamo Therapeutics
layoffs
Flag link:
Fresh layoffs at Nektar Therapeutics as it drops lupus program after phase 2 disappointment
Fresh layoffs at Nektar Therapeutics as it drops lupus program after phase 2 disappointment
Biopharma Reporter
Nektar Therapeutics
lupus
rezpegaldesleukin
layoffs
Rezpeg
Flag link:
After lupus setback, Nektar sticks with immunology but lays off 70% of hometown workforce
After lupus setback, Nektar sticks with immunology but lays off 70% of hometown workforce
Fierce Biotech
Nektar Therapeutics
reorganization
layoffs
Flag link:
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Fierce Biotech
layoffs
biotech
Flag link:
Faced with rocky interim data for rare disease drug, Aeglea lays off more staff and seeks exit route
Faced with rocky interim data for rare disease drug, Aeglea lays off more staff and seeks exit route
Fierce Biotech
Aeglea BioTherapeutics
layoffs
pegtarviliase
Flag link:
Biotech layoffs gather pace as industry downturn persists
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Flag link:

Pages